Adult Eczema Study (18yrs +)
This study is being done to see how safe baricitinib is and how well it might work to help people with moderate-to-severe atopic dermatitis (eczema).

Adult Eczema Study (18 yrs +)
This study is to assess the efficacy of four dose regimens of KHK4083 compared to placebo as measured by the change from baseline. In addition to evaluate the safety of multiple injections of KHK4083 in subjects with moderate-to-severe atopic dermatitis.

Eczema Study (12 yrs +)
The purpose of this study is to compare effects of PF-04965842 (the study drug) with a placebo to find out which is better for treating atopic dermatitis for persons with moderate to severe eczema over the age of 12.

Adult Eczema Study (18 yrs to 65 yrs)
The purpose of this study is to determine how study drug dupilumab affects the amount of bacteria on the skin, the skin's water loss and the immune system for subjects with moderate-to-severe atopic dermatitis.

Eczema Study (3 yrs to 85 yrs)
The purpose of this study is to determine why some individuals with atopic dermatitis are at higher risk for recurrent skin infections with herpes simplex virus (HSV).

Pediatric Eczema Study (6 yrs to 12 yrs)
This study is to find out how effective and safe dupilumab (the investigational drug) with topical corticosteroids is in people suffering from atopic dermatitis.

There are no psoriasis trials active at this time. Feel free to utilize our Contact Form, to be contacted when a psoriasis trial opens in the future.

War on Melanoma: Enlisting a cohort of melanoma survivors and their families
The purpose of this data repository, called the Melanoma Community Registry, is to develop a prospective cohort of melanoma patients, family members and friends (controls). This registry will serve as a data repository for future IRB-approved research and thus will collect, store and share data with melanoma researchers for an indeterminate period of time. In addition, our repository will contain identifying codes/numbers that are links to data/samples in other relevant databases. Additionally, it is intended to deliver a ready-to-act group of volunteers to participate in the War on Melanoma campaign to include such things as attending educational symposiums and using their networks to increase awareness of the issue. There is no existing nationwide registry for melanoma research. As patient-centered research advances, a resource like this is needed and can serve as a model.